A Cohort Study Comparing IFX to CS for Moderate to Severe UC

NCT04879966 · clinicaltrials.gov ↗

UNKNOWN

Status

342

Enrollment

OTHER

Sponsor class

Conditions

Moderate to Severe Ulcerative Colitis

Interventions

DRUG: Infliximab
DRUG: Corticosteroid

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University